System zur Abgabe einer Tobramycin-Formulierung

European patent · EP1320355 · Deleted

Register entry

Publication number
EP1320355
Application number
EP02771857
Kind
European patent with effect for Switzerland and Liechtenstein
Status
Deleted
Specification
Granted
Filed
May 17, 2002
Published
Jun 25, 2003
Granted
Apr 5, 2006
Deleted
Apr 5, 2006
Reason
Revoked in opposition
IPC classes
A61K 9/00 (2006.01)
A61K 9/12 (2006.01)
A61K 31/7036 (2006.01)
Priority
US 292234 P 18.05.2001
PCT application
PCT/US2002/015999 17.05.2002
PCT publication
WO2002/094217 28.11.2002
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Jun 25, 2024

    Change

    Published in Swissreg on 25.06.2024

  2. Jul 9, 2010

    Change

    Published in Swissreg on 09.07.2010

  3. Feb 29, 2008

    Address changed

    Owner
    CHIRON CORPORATION, 4560 Horton Street, Emeryville, California 94608-2916, USA → NOVARTIS VACCINES & DIAGNOSTICS, INC., 4560 Horton Street, Emeryville, CA 94608-2916, USA

    Published in +pat+ No 4 in 2008

  4. Jul 31, 2006

    Agent entered

    Representative
    Patentanwälte, Schaad, Balass, Menzl & Partner AG, Dufourstrasse 101, 8034 Zürich

    Published in +pat+ No 14 in 2006

  5. Apr 13, 2006

    Granted

    Published in +pat+ No 7 in 2006

Parties

Inventor

SPEIRS, Robert, J.

Lynwood, WA 98037, US

SCHAEFFLER, Barbara, A.

Seattle, WA 98103, US

CHALLONER, Peter, B.

Seattle, WA 98109, US

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.